Tauopathies, including AD, CBD, and PSP, arise from convergent pathogenic processes encompassing Tau hyperphosphorylation 46–48, impaired proteostasis 49,50, synaptic dysfunction 51,52, and chronic neuroinflammation 4,5. The gene discussed is MAPT; the disease is tauopathy.